( S ( NP-SBJ-1 ( NP ( DT The ) ( NN drug ) ) ( VP ( VBD introduced ) ( NP-TMP ( JJ last ) ( NN year ) ) ) ) ( VP ( VBZ is ) ( VP ( VBN expected ) ( S ( VP ( TO to ) ( VP ( VB generate ) ( NP ( NP ( NNS sales ) ) ( PP ( IN of ) ( NP ( QP ( RB about ) ( CD 300 ) ( CD million ) ) ) ) ) ( NP-TMP ( DT this ) ( NN year ) ) ) ) ) ) ) )